Non-Hispanic blacks are less likely to receive opioid prescription at discharge during emergency room visits for back pain and abdominal pain compared with non-Hispanic whites, researchers found.
There are significant racial-ethnic disparities regarding how opioids are prescribed for pain relief in the emergency department (ED), with non-Hispanic blacks being less likely to receive opioid prescription at discharge during ED visits for back pain and abdominal pain—but not for toothache, fractures, and kidney stones—compared with non-Hispanic whites. The findings, by Astha Singhal, DMD, PhD, of the Boston University School of Dental Medicine, and colleagues, were published in PLOS ONE.
Although inadequately treated pain in the ED is a major national concern, the abuse of prescription opioids is the fastest-growing drug problem in the nation, and has overtaken use of cocaine and heroin combined as a cause of death. In an attempt to confront opioid abuse and reduce prescribing of opioids to drug abusers, guidelines have been developed for physicians to determine whether a patient is a drug abuser. But it is often impossible for physicians, especially those in the ED, to definitively make the judgment as to whether a patient is a drug abuser when they come to the ED with pain-related complaints.
Thus ED physicians must rely on cues, possibly without being conscious of them, to quickly determine whether or not to prescribe opioids. Singhal and colleagues hypothesized that there was differential prescribing of opioids by race-ethnicity, which could lead to a widening of existing health disparities and may have implications for the disproportionate burden of opioid abuse among whites.
Unlike previous studies, this one differentiates between whether opioids were administered in the ED or prescribed at discharge. The distinction was used by the researchers to further elucidate the role of race and ethnicity for 2 reasons: 1) nonwhite race is one of the largest predictors of provider mistrust, and prescribing opioids at discharge requires a high level of provider-patient trust; and 2) while prescribing opioids contributes to the prescription opioid epidemic, one-time administration of opioid in the ED does so minimally.
The study categorized patients into non-Hispanic white, non-Hispanic black, Hispanic, and non-Hispanic other categories. The investigators also categorized patients by pain severity and patients’ condition into non-definitive (such as back pain or abdominal pain, which typically have no visible clinical or diagnostic presentations) and definitive (pain-related conditions such as long-bone fracture and kidney stones that have objective clinical presentations and can be confirmed with simple diagnostic tools). The latter distinction was created to see if racial-ethnic disparities would be present in opioid prescribing for non-definitive conditions that have been associated with drug-seeking behavior, but not for definitive conditions.
Investigators used 2007-2011 data from the National Hospital Ambulatory Medical Care Survey, which is based on a national sample of visits to the ED, outpatient departments, and ambulatory surgical centers that is made available by the CDC. The study analyzed all ED visits made by adults aged 18 to 65 years. After adjusting for other covariates, the investigators found that non-Hispanic black patients were less likely to receive opioid prescriptions at ED discharge during visits for back pain and abdominal pain, but not for toothache, fractures, and kidney stones, compared with non-Hispanic whites.
“Our study shows that there are significant racial-ethnic disparities in opioid prescription and administration in ED visits for non-definitive conditions,” they concluded. “These disparities may reflect inherent biases that health care providers hold unknowingly, leading to differential treatment of patients based on their race.”
The authors say their findings have important implications for medical provider education, suggesting that sensitization exercises be included to enable them to consciously avoid these biases from defining their practice behavior.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More